• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Trader's Daily Notebook: Trading Without a Net

Give dip buyers the benefit of the doubt on Wednesday.
By BOB BYRNE May 17, 2017 | 07:00 AM EDT
Stocks quotes in this article: QQQ, IWM, DIA, SPY, NVDA, AMAT, COHR, LITE, ATHM, MOMO, EDU, TAL, MELI

Leap, and the net will appear

- John Burroughs

Tuesday's auction turned out OK for momentum oriented tech bulls, but for those not focused on the NASDAQ 100 and the PowerShares QQQ Trust (QQQ) , which gained more than 0.4% on the day, the session was a wash. Both the iShares Russell 2000 Index ETF (IWM) and SPDR Dow Jones Industrial Average ETF (DIA) finished pennies in the black, while the SPDR S&P 500 Trust (SPY) lost roughly 0.1% during the regular session.

Some of Tuesday's winners were names that have been running for a while now. Stocks like NVIDIA (NVDA) , Applied Materials (AMAT) , Coherent (COHR) , Lumentum Holdings (LITE) , Autohome  (ATHM) , Momo  (MOMO) , New Oriental Education and Tech (EDU) and Tal Education Group (TAL) . All these stocks have sky-high Relative Strength index (RSI) readings. All of them are in well defined uptrends. And for the most part, all have accelerating earnings. And at least according to the fine folks at Investor's Business Daily, who have had several of these stocks in their IBD 50 stock list for a considerable amount of time, these are all fantastic stocks based on both technicals and fundamentals.

I won't argue with the bullish momentum behind any of the aforementioned names. In fact, as long as the tape remains strong and demand for these sorts of stocks remains insatiable, I'll look for any reason whatsoever to buy them. That's short-term trading. However, if you're trading these types of names, be it during the day timeframe or over a multi-session basis, you'd better be quick to recognize when the insatiable demand morphs into an gushing river of supply.

There's no question index traders looking to remain active during times when the E-Mini S&P 500 futures (Es) flatlines and fails to rotate within a reasonable range need to venture outside the confines of their protective bubbles. Just keep in mind momentum is a two-way street. And no matter how wonderful you believe a stock like MercadoLibre  (MELI) is, or how fantastic NVIDIA's earnings report was, you aren't John Burroughs. That net you hope will always exist under powerfully trending momentum stocks has a nasty way of disappearing at a moment's notice.

Moving on to Wednesday's auction, we'll continue to give dip buyers the benefit of the doubt, but only while also respecting the shocking lack of follow through from the May 5 rally to new swing highs.

View Chart »  View in New Window »

We'll begin Wednesday's auction focused on 2397. Weakness beneath that figure, while still 3.25-handles above Tuesday's regular session low, opens the door to selling toward 2388.50 to 2390. Value migration beneath 2388.50 to 2390 would begin to give the recent break above that area (beginning with the close on May 5) the look of a false breakout. But I still believe most intermediate timeframe traders will use a level closer to 2379 as their line in the sand.

View Chart »  View in New Window »

All trading above 2397 keeps the contract bouncing back and forth between it and 2401. A sustained trade above 2401 encourages buying toward Tuesday's 2404.50 intraday high, and on to new swing highs.

Any trading or volume profile related questions can be posted in the comments section below, emailed to me at parkcityyeti@gmail.com or posted to my twitter feed @ByrneRWS

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Healthcare | Markets | How-to | Stocks

More from Healthcare

Two Dividend Stocks I Own and One I'm Looking to Buy

Dave Butler
Feb 13, 2019 3:23 PM EST

These stocks aren't going out of style.

Ventas Is Showing Some Softness Now, Raise Sell Stop Protection

Bruce Kamich
Feb 13, 2019 9:26 AM EST

The company is relying on several building blocks to return to growth.

Evolus Stockholders May Be Frowning in the Short Run

Bruce Kamich
Feb 8, 2019 10:41 AM EST

Shares of the Botox competitor could correct/consolidate after a recent surge.

Centene Splits 2 For 1 Which Changes the Chart Levels but Not the Trends

Bruce Kamich
Feb 7, 2019 9:45 AM EST

With the stock split a fresh look at the split adjusted stock is now in order.

Alphabet's Healthcare Initiative Squares Off With Amazon, Apple

Kevin Curran
Feb 4, 2019 4:03 PM EST

Healthcare is attracting some very healthy competition among mega-cap names.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:01 PM EST KEVIN CURRAN

    Pepsi Kicks off 2019 on a Positive Note

    Pepsi's earnings may not have been immaculate, but...
  • 10:08 AM EST BOB LANG

    Rolling up the Arista

    on Tuesday this week I posted a trade idea here an...
  • 08:11 AM EST KEVIN CURRAN

    Pepsi Earnings Call Notes

    As my first article is in edit, here are some sele...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login